New Senate Bill Would Give Terminally Ill the ‘Right to Try’ Psychedelic Therapies
Hospice News
JULY 21, 2022
If enacted, the bill would clarify that patients receiving end-of-life care could access Schedule 1 controlled substances that have undergone a Phase 1 clinical trial, including MDMA and psilocybin. Unfortunately, many eligible patients who urgently need care do not currently have access to these promising therapies.” .
243 
Let's personalize your content